Using Advanced Molecular Profiling to Identify the Origin of and Tailor Treatment for an Intracranial Mass of Unknown Primary

por Martinez, Francisco, Brucks, Eric, Otsuji, Janelle, Mehnoor, Haseeb, Arif-Tiwari, Hina, Babiker, Hani M., Recio-Boiles, Alejandro
Publicado 2021

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer

por Gerratana, Lorenzo, Davis, Andrew A., Zhang, Qiang, Basile, Debora, Rossi, Giovanna, Strickland, Kimberly, Franzoni, Alessandra, Allegri, Lorenzo, Mu, Zhaomei, Zhang, Youbin, Flaum, Lisa E., Damante, Giuseppe, Gradishar, William John, Platanias, Leonidas C., Behdad, Amir, Yang, Hushan, Puglisi, Fabio, Cristofanilli, Massimo
Publicado 2021

Analytical Concordance of PD-L1 Assays Utilizing Antibodies From FDA-Approved Diagnostics in Advanced Cancers: A Systematic Literature Review

por Prince, Emily A., Sanzari, Jenine K., Pandya, Dimple, Huron, David, Edwards, Robin
Publicado 2021

Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer From SOLAR-1

por Ciruelos, Eva Maria, Rugo, Hope S., Mayer, Ingrid A., Levy, Christelle, Forget, Frédéric, Delgado Mingorance, Juan Ignacio, Safra, Tamar, Masuda, Norikazu, Park, Yeon Hee, Juric, Dejan, Conte, Pierfranco, Campone, Mario, Loibl, Sibylle, Iwata, Hiroji, Zhou, Xiaolei, Park, Jinhee, Ridolfi, Antonia, Lorenzo, Ines, André, Fabrice
Publicado 2021

Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

por Hutchings, Martin, Morschhauser, Franck, Iacoboni, Gloria, Carlo-Stella, Carmelo, Offner, Fritz C., Sureda, Anna, Salles, Gilles, Martínez-Lopez, Joaquín, Crump, Michael, Thomas, Denise N., Morcos, Peter N., Ferlini, Cristiano, Bröske, Ann-Marie E., Belousov, Anton, Bacac, Marina, Dimier, Natalie, Carlile, David J., Lundberg, Linda, Perez-Callejo, David, Umaña, Pablo, Moore, Tom, Weisser, Martin, Dickinson, Michael J.
Publicado 2021

OncoAlert Round Table Discussions: The Global COVID-19 Experience

por Morgan, Gilberto, de Azambuja, Evandro, Punie, Kevin, Ades, Felipe, Heinrich, Kathrin, Personeni, Nicola, Rahme, Ramy, Ferrara, Roberto, Pels, Kevin, Garassino, Marina, von Bergwelt-Baildon, Michael, Lopes, Gilberto, Barlesi, Fabrice, Choueiri, Toni K., Burris, Howard, Peters, Solange
Publicado 2021

Global Implementation of Precision Oncology

por Yam, Clinton, Ma, Brigette B. Y., Yap, Timothy A.
Publicado 2021

Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment

por Soong, Deborah, Kumar, Priyadarshini, Jatwani, Karan, Park, Jae, Dogan, Ahmet, Taylor, Justin
Publicado 2021

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health

por Williams, P. Mickey, Forbes, Thomas, P. Lund, Steven, Cole, Kenneth D., He, Hua-Jun, Karlovich, Chris, Paweletz, Cloud P., Stetson, Daniel, Yee, Laura M., Connors, Dana E., Keating, Susan M., Destenaves, Benoit, Cleveland, Megan H., Lau, Christie J., Barrett, J. Carl, Kelloff, Gary J., McCormack, Robert T.
Publicado 2021

Recurrent Myocarditis Induced by Immune-Checkpoint Inhibitor Treatment Is Accompanied by Persistent Inflammatory Markers Despite Immunosuppressive Treatment

por Aghel, Nazanin, Gustafson, Dakota, Di Meo, Ashley, Music, Milena, Prassas, Ioannis, Seidman, Michael A., Hansen, Aaron R., Thavendiranathan, Paaladinesh, Diamandis, Eleftherios P., Delgado, Diego, Fish, Jason E.
Publicado 2021

Comprehensive Breast Cancer Risk Assessment for CHEK2 and ATM Pathogenic Variant Carriers Incorporating a Polygenic Risk Score and the Tyrer-Cuzick Model

por Gallagher, Shannon, Hughes, Elisha, Kurian, Allison W., Domchek, Susan M., Garber, Judy, Probst, Braden, Morris, Brian, Tshiaba, Placede, Meek, Stephanie, Rosenthal, Eric, Roa, Benjamin, Slavin, Thomas P., Wagner, Susanne, Weitzel, Jeffrey, Gutin, Alexander, Lanchbury, Jerry S., Robson, Mark
Publicado 2021

Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy

por Cmero, Marek, Kurganovs, Natalie J., Stuchbery, Ryan, McCoy, Patrick, Grima, Corrina, Ngyuen, Anne, Chow, Ken, Mangiola, Stefano, Macintyre, Geoff, Howard, Nicholas, Kerger, Michael, Dundee, Philip, Ruljancich, Paul, Clarke, David, Grummet, Jeremy, Peters, Justin S., Costello, Anthony J., Norden, Sam, Ryan, Andrew, Parente, Phillip, Hovens, Christopher M., Corcoran, Niall M.
Publicado 2021

Clinical Inflection Point Detection on the Basis of EHR Data to Identify Clinical Trial–Ready Patients With Cancer

por Kehl, Kenneth L., Groha, Stefan, Lepisto, Eva M., Elmarakeby, Haitham, Lindsay, James, Gusev, Alexander, Van Allen, Eliezer M., Hassett, Michael J., Schrag, Deborah
Publicado 2021

Bayesian Framework to Augment Tumor Board Decision Making

por Pasetto, Stefano, Gatenby, Robert A., Enderling, Heiko
Publicado 2021

Clinical Outcomes of Molecular Tumor Boards: A Systematic Review

por Larson, Kara L., Huang, Bin, Weiss, Heidi L., Hull, Pam, Westgate, Philip M., Miller, Rachel W., Arnold, Susanne M., Kolesar, Jill M.
Publicado 2021

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer

por Schouten, Robert D., Vessies, Daan C. L., Bosch, Linda J. W., Barlo, Nicole P., van Lindert, Anne S. R., Cillessen, Saskia A. G. M., van den Broek, Daan, van den Heuvel, Michel M., Monkhorst, Kim
Publicado 2021

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

por Mayor, Neema P., Wang, Tao, Lee, Stephanie J., Kuxhausen, Michelle, Vierra-Green, Cynthia, Barker, Dominic J., Auletta, Jeffrey, Bhatt, Vijaya R., Gadalla, Shahinaz M., Gragert, Loren, Inamoto, Yoshihiro, Morris, Gerald P., Paczesny, Sophie, Reshef, Ran, Ringdén, Olle, Shaw, Bronwen E., Shaw, Peter, Spellman, Stephen R., Marsh, Steven G. E.
Publicado 2021

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

por Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G., Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leal, Ticiana A., Riess, Jonathan W., Jensen, Erin, Zhao, Bin, Pietanza, M. Catherine, Brahmer, Julie R.
Publicado 2021

Open-Label, Single-Arm, Multicenter, Phase II Trial of Lenvatinib for the Treatment of Patients With Anaplastic Thyroid Cancer

por Wirth, Lori J., Brose, Marcia S., Sherman, Eric J., Licitra, Lisa, Schlumberger, Martin, Sherman, Steven I., Bible, Keith C., Robinson, Bruce, Rodien, Patrice, Godbert, Yann, De La Fouchardiere, Christelle, Newbold, Kate, Nutting, Christopher, Misir, Soamnauth, Xie, Ran, Almonte, Ana, Ye, Weifei, Cabanillas, Maria E.
Publicado 2021

TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhi...

por Tagawa, Scott T., Balar, Arjun V., Petrylak, Daniel P., Kalebasty, Arash Rezazadeh, Loriot, Yohann, Fléchon, Aude, Jain, Rohit K., Agarwal, Neeraj, Bupathi, Manojkumar, Barthelemy, Philippe, Beuzeboc, Philippe, Palmbos, Phillip, Kyriakopoulos, Christos E., Pouessel, Damien, Sternberg, Cora N., Hong, Quan, Goswami, Trishna, Itri, Loretta M., Grivas, Petros
Publicado 2021